Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$233.08 - $265.59 $2.05 Million - $2.34 Million
-8,815 Reduced 4.2%
201,298 $49.9 Million
Q2 2023

Aug 11, 2023

SELL
$224.99 - $256.14 $20.3 Million - $23.1 Million
-90,271 Reduced 30.05%
210,113 $50.4 Million
Q1 2023

May 15, 2023

SELL
$239.75 - $277.0 $5.76 Million - $6.65 Million
-24,008 Reduced 7.4%
300,384 $75.7 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $1.85 Million - $2.16 Million
-7,665 Reduced 2.31%
324,392 $86.1 Million
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $1.02 Million - $6.25 Million
4,146 Added 1.26%
332,057 $85.8 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $1.99 Million - $2.52 Million
-8,407 Reduced 2.5%
327,911 $83.1 Million
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $1.48 Million - $1.81 Million
5,740 Added 1.74%
336,318 $98.7 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $5.81 Million - $6.54 Million
-19,890 Reduced 5.68%
330,578 $109 Million
Q3 2021

Nov 03, 2021

SELL
$272.21 - $332.43 $814,452 - $994,630
-2,992 Reduced 0.85%
350,468 $107 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $2.82 Million - $3.4 Million
-12,516 Reduced 3.42%
353,460 $94.9 Million
Q1 2021

May 13, 2021

SELL
$212.38 - $245.9 $125,941 - $145,818
-593 Reduced 0.16%
365,976 $82.4 Million
Q4 2020

Feb 12, 2021

SELL
$212.5 - $245.46 $1.13 Million - $1.3 Million
-5,306 Reduced 1.43%
366,569 $81.4 Million
Q3 2020

Nov 13, 2020

BUY
$177.16 - $215.33 $1.72 Million - $2.1 Million
9,735 Added 2.69%
371,875 $80.1 Million
Q2 2020

Aug 14, 2020

BUY
$128.7 - $176.83 $837,450 - $1.15 Million
6,507 Added 1.83%
362,140 $64 Million
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $353,487 - $492,273
-2,912 Reduced 0.81%
355,633 $49.2 Million
Q4 2019

Feb 11, 2020

SELL
$133.47 - $153.48 $87,556 - $100,682
-656 Reduced 0.18%
358,545 $55 Million
Q3 2019

Nov 12, 2019

SELL
$135.4 - $146.47 $3.13 Million - $3.38 Million
-23,084 Reduced 6.04%
359,201 $51.9 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $203,554 - $234,279
-1,630 Reduced 0.42%
382,285 $0
Q1 2019

May 15, 2019

SELL
$97.62 - $132.29 $206,368 - $279,661
-2,114 Reduced 0.55%
383,915 $0
Q4 2018

Feb 15, 2019

BUY
$94.85 - $109.54 $966,142 - $1.12 Million
10,186 Added 2.71%
386,029 $39.8 Million
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $316,763 - $351,529
-3,228 Reduced 0.85%
375,843 $0
Q2 2018

Aug 08, 2018

BUY
$96.1 - $103.24 $4.68 Million - $5.03 Million
48,698 Added 14.74%
379,071 $0
Q1 2018

May 16, 2018

SELL
$92.16 - $103.8 $551,485 - $621,139
-5,984 Reduced 1.78%
330,373 $0
Q4 2017

Feb 15, 2018

SELL
$85.26 - $94.62 $399,357 - $443,200
-4,684 Reduced 1.37%
336,357 $0
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $27 Million - $30.2 Million
341,041
341,041 $0

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.